545 related articles for article (PubMed ID: 9488791)
21. Contraceptive choices in women with coagulation disorders.
Comp PC; Zacur HA
Am J Obstet Gynecol; 1993 Jun; 168(6 Pt 2):1990-3. PubMed ID: 8512043
[TBL] [Abstract][Full Text] [Related]
22. Effects of oral contraceptives on hemostasis and thrombosis.
Rosing J; Tans G
Am J Obstet Gynecol; 1999 Jun; 180(6 Pt 2):S375-82. PubMed ID: 10368524
[TBL] [Abstract][Full Text] [Related]
23. Hemostatic and metabolic effects of lowering the ethinyl-estradiol dose from 30 mcg to 20 mcg in oral contraceptives containing desogestrel.
Basdevant A; Conard J; Pelissier C; Guyene TT; Lapousterle C; Mayer M; Guy-Grand B; Degrelle H
Contraception; 1993 Sep; 48(3):193-204. PubMed ID: 8222650
[TBL] [Abstract][Full Text] [Related]
24. Changes in haemostasis after stopping the combined contraceptive pill: implications for major surgery.
Robinson GE; Burren T; Mackie IJ; Bounds W; Walshe K; Faint R; Guillebaud J; Machin SJ
BMJ; 1991 Feb; 302(6771):269-71. PubMed ID: 1998792
[TBL] [Abstract][Full Text] [Related]
25. Smoking and use of oral contraceptives: impact on thrombotic diseases.
Lidegaard O
Am J Obstet Gynecol; 1999 Jun; 180(6 Pt 2):S357-63. PubMed ID: 10368521
[TBL] [Abstract][Full Text] [Related]
26. Enhancement by factor V Leiden mutation of risk of deep-vein thrombosis associated with oral contraceptives containing a third-generation progestagen.
Bloemenkamp KW; Rosendaal FR; Helmerhorst FM; Büller HR; Vandenbroucke JP
Lancet; 1995 Dec; 346(8990):1593-6. PubMed ID: 7500751
[TBL] [Abstract][Full Text] [Related]
27. Effect of desogestrel-containing oral contraceptives on vascular reactivity and catecholamine levels.
Arangino S; Cagnacci A; Angiolucci M; Longu G; Melis GB; Volpe A
Contraception; 1998 Nov; 58(5):289-93. PubMed ID: 9883384
[TBL] [Abstract][Full Text] [Related]
28. Effects of long-term gestodene-containing oral contraceptive administration on hemostasis.
Abbate R; Pinto S; Rostagno C; Bruni V; Rosati D; Mariani G
Am J Obstet Gynecol; 1990 Jul; 163(1 Pt 2):424-9. PubMed ID: 2372036
[TBL] [Abstract][Full Text] [Related]
29. An epidemiological study of the haemostatic and other effects of oral contraceptives.
Meade TW; Brozović M; Chakrabarth R; Howarth DJ; North WR; Stirling Y
Br J Haematol; 1976 Nov; 34(3):353-64. PubMed ID: 990177
[TBL] [Abstract][Full Text] [Related]
30. Effects of oral contraceptives on blood coagulation. A review.
Beller FK; Ebert C
Obstet Gynecol Surv; 1985 Jul; 40(7):425-36. PubMed ID: 3895067
[TBL] [Abstract][Full Text] [Related]
31. Population-based study of risk of venous thromboembolism associated with various oral contraceptives.
Farmer RD; Lawrenson RA; Thompson CR; Kennedy JG; Hambleton IR
Lancet; 1997 Jan; 349(9045):83-8. PubMed ID: 8996419
[TBL] [Abstract][Full Text] [Related]
32. Coagulation effects of oral contraception.
Bonnar J
Am J Obstet Gynecol; 1987 Oct; 157(4 Pt 2):1042-8. PubMed ID: 2960241
[TBL] [Abstract][Full Text] [Related]
33. Oral contraceptives and blood coagulation.
Bonnar J; Sabra AM
J Reprod Med; 1986 Jun; 31(6 Suppl):551-6. PubMed ID: 2941571
[TBL] [Abstract][Full Text] [Related]
34. [Cardiovascular risks of oral contraceptives: dose-response relationship].
Kelleher CC
Contracept Fertil Sex (Paris); 1991 Apr; 19(4):285-8. PubMed ID: 12343220
[TBL] [Abstract][Full Text] [Related]
35. Comparison of metabolic and clinical effects of four oral contraceptive formulations and a contraceptive vaginal ring.
Roy S; Mishell DR; Gray G; Dozono-Takano R; Brenner PF; Eide I; de Quattro V; Shaw ST
Am J Obstet Gynecol; 1980 Apr; 136(7):920-31. PubMed ID: 6767404
[TBL] [Abstract][Full Text] [Related]
36. Oral contraceptives, anti-thrombin III and fibrinolytic activity in Africans.
Greig HB
Acta Haematol; 1977; 58(3):138-44. PubMed ID: 409028
[TBL] [Abstract][Full Text] [Related]
37. Ethinylestradiol 20 versus 30 micrograms combined with 150 micrograms desogestrel: a large comparative study of the effects of two low-dose oral contraceptives on the hemostatic system.
Winkler UH; Hölscher T; Schulte H; Zierleyn JP; Collet W; Schindler AE
Gynecol Endocrinol; 1996 Aug; 10(4):265-71. PubMed ID: 8908527
[TBL] [Abstract][Full Text] [Related]
38. Oral contraceptives, clotting factors, and thrombosis.
Meade TW
Am J Obstet Gynecol; 1982 Mar; 142(6 Pt 2):758-61. PubMed ID: 6801980
[TBL] [Abstract][Full Text] [Related]
39. Oestriol deficiency, a possible factor in the aetiology of thrombo-embolism in pill users.
Zaki K; Sami G; Nour H
Egypt Popul Fam Plann Rev; 1972 Jun; 5(1):19-24. PubMed ID: 12256026
[TBL] [Abstract][Full Text] [Related]
40. Decreased plasma tissue factor pathway inhibitor in women taking combined oral contraceptives.
Harris GM; Stendt CL; Vollenhoven BJ; Gan TE; Tipping PG
Am J Hematol; 1999 Mar; 60(3):175-80. PubMed ID: 10072106
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
